Page 1

NEVER SAY NEVER ROHTO Consolidated Financial Results for the Fiscal Year Ended March 31 , 2021 Company name : ROHTO Pharmaceutical Co. , Ltd. Stock code : Representative : Contact : Telephone : 4527 Masashi Sugimoto , President and COO Masaya Saito , Vice President and Director 81- ( 0 ) 6-6758-8223 Scheduled date of Annual General Meeting of Shareholders : Scheduled date of filing of Annual Securities Report : Scheduled date of dividend payment : Supplementary materials for financial results : Financial results meeting : May 12 , 2021 [ Japanese GAAP ] Stock Exchange listing : TSE , First Section URL : https://www.rohto.co.jp/ June 24 , 2021 June 25 , 2021 June 10 , 2021 Yes Yes ( for institutional investors and analysts ) ( All amounts are rounded down to the nearest million yen . ) 1. Consolidated Financial Results for the Fiscal Year Ended March 31 , 2021 ( April 1 , 2020 – March 31 , 2021 ) ( 1 ) Consolidated results of operations ( Percentages represent year - on - year changes . ) Net sales Operating income Ordinary income Millions of yen % Millions of yen % Millions of yen Fiscal year ended Mar. 31 , 2021 181,287 ( 3.7 ) 22,990 ( 0.4 ) 23,910 Fiscal year ended Mar. 31 , 2020 188,327 2.6 23,085 10.9 22,735 % 5.2 19.8 Profit attributable to owners of parent Millions of yen % 16,743 8.6 15,410 57.3 Note : Comprehensive income ( Millions of yen ) : Fiscal year ended Mar. 31 , 2021 : Fiscal year ended Mar. 31 , 2020 : 19,794 75.6 % 11,275 83.7 % Diluted net Ordinary Basic net income per share income per ROE income Operating income to net sales share on total assets Fiscal year ended Mar. 31 , 2021 Yen 146.78 Yen % % 135.13 Fiscal year ended Mar. 31 , 2020 Reference : Equity in earnings of affiliates ( Millions of yen ) : Fiscal year ended Mar. 31 , 2021 : Fiscal year ended Mar. 31 , 2020 : Note : The provisional accounting treatment for business combinations has been finalized in the current fiscal year . The figures for the fiscal year ended March 31 , 2020 have been restated accordingly . 146.36 134.71 11.7 11.4 10.8 % 12.7 10.9 12.3 396 ( 1,192 ) ( 2 ) Consolidated financial position As of Mar. 31 , 2021 Total assets Millions of yen 225,790 Net assets Equity ratio Net assets per share 215,644 Millions of yen 156,612 140,032 % 68.9 Yen 64.4 1,363.42 1,217.67 As of Mar. 31 , 2020 Reference : Shareholders ' equity ( Millions of yen ) : As of Mar. 31 , 2021 : 155,525 As of Mar. 31 , 2020 : 138,899 Note : The provisional accounting treatment for business combinations has been finalized in the current fiscal year . The figures for the fiscal year ended March 31 , 2020 have been restated accordingly . ( 3 ) Consolidated cash flows Fiscal year ended Mar. 31 , 2021 Fiscal year ended Mar. 31 , 2020 Cash flows from operating activities Millions of yen 20,008 19,040 Cash flows from investing activities Millions of yen ( 10,237 ) ( 9,405 ) Cash flows from financing activities Millions of yen ( 2,347 ) ( 1,603 ) Cash and cash equivalents at end of period Millions of yen 52,254 44,665